Advanced Non-small-cell Lung Cancer Clinical Trial
Official title:
Multimodality Treatment Including Curative Resection of Advanced Stage Non-small Cell Lung Cancer - an Explorative, Retrospective Pilot Study
This study retrospectively evaluates clinical parameters and outcome of patients with advanced stage non-small cell lung cancer treated with neoadjuvant therapy followed by curative-intent surgery at the Divison of Thoracic Surgery at the Medical University of Vienna
This study will be undertaken as a retrospective cohort study at Devision of Thoracic Surgery, Medical University of Vienna. All patients with non-small-cell lung cancer, who received an induction chemo- or chemoradiotherapy followed by surgery in a curative intention at the Devision of Thoracic Surgery, Medical University, will be included. The aim of this study is to evaluate peri- and postoperative clinical parameters and short- and long-term outcomes in patients. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05435274 -
Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
Enrolling by invitation |
NCT05192681 -
Tislelizumab as Cross-line Treatment for Advanced NSCLC
|
Phase 2 | |
Active, not recruiting |
NCT05499390 -
AK112 in Advanced Non-Small Cell Lung Cancer
|
Phase 3 | |
Not yet recruiting |
NCT04733521 -
A Phase 1/2 Study of SC-43 in Combination With Cisplatin
|
Phase 1/Phase 2 | |
Completed |
NCT05380908 -
Brain Metabolic Network of PET in Patients With Advanced Non-Small Cell Lung Cancer
|
||
Recruiting |
NCT05904379 -
AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer
|
Phase 1/Phase 2 |